Targeting of marrow-derived astrocytes to the ischemic brain
- 1 April 1999
- journal article
- research article
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 10 (6) , 1289-1292
- https://doi.org/10.1097/00001756-199904260-00025
Abstract
BONE marrow progenitor cells have been shown to contribute to a small proportion of cells in nonhematopoietic tissues including the brain. In the acute unilateral middle cerebral artery occlusion model in spontaneously hypertensive rats following male-to-female bone marrow transplantation, we present data suggesting that 55% more marrow-derived cells, in general, and 161% more GFAP-positive astrocytes, in particular, migrate preferentially to the ischemic cortex than to the contralateral non-ischemic hemisphere. In addition to their biological significance, our findings could have therapeutic implications. Marrow-derived progenitor cells could potentially be used as vehicles for ex vivo gene transfer to the brain.Keywords
This publication has 6 references indexed in Scilit:
- Kinetics of Central Nervous System Microglial and Macrophage Engraftment: Analysis Using a Transgenic Bone Marrow Transplantation ModelBlood, 1997
- Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult miceProceedings of the National Academy of Sciences, 1997
- Marrow Stromal Cells as Stem Cells for Nonhematopoietic TissuesScience, 1997
- Postischemic Neuronal Damage Causes Astroglial Activation and Increase in Local Cerebral Glucose Utilization of Rat HippocampusJournal of Cerebral Blood Flow & Metabolism, 1991
- Perivascular Microglial Cells of the CNS Are Bone Marrow-Derived and Present Antigen in VivoScience, 1988
- Cell proliferation after ischemic injury in gerbil brainCell and tissue research, 1985